These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11162833)

  • 1. The Epstein-Barr virus latent membrane protein 1 induces interleukin-10 in Burkitt's lymphoma cells but not in Hodgkin's cells involving the p38/SAPK2 pathway.
    Vockerodt M; Haier B; Buttgereit P; Tesch H; Kube D
    Virology; 2001 Feb; 280(2):183-98. PubMed ID: 11162833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus latent membrane protein-1 activates CD25 expression in lymphoma cells involving the NFkappaB pathway.
    Vockerodt M; Tesch H; Kube D
    Genes Immun; 2001 Dec; 2(8):433-41. PubMed ID: 11781710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of intercellular adhesion molecule-1 regulation by Epstein-Barr virus-encoded latent membrane protein-1 identifies pathways that cooperate with nuclear factor kappa B to activate transcription.
    Mehl AM; Floettmann JE; Jones M; Brennan P; Rowe M
    J Biol Chem; 2001 Jan; 276(2):984-92. PubMed ID: 11034993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Epstein-Barr virus oncoprotein latent membrane protein 1 induces expression of the chemokine IP-10: importance of mRNA half-life regulation.
    Vockerodt M; Pinkert D; Smola-Hess S; Michels A; Ransohoff RM; Tesch H; Kube D
    Int J Cancer; 2005 Apr; 114(4):598-605. PubMed ID: 15578697
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epstein-Barr virus latent membrane protein-1 (LMP1) signalling is distinct from CD40 and involves physical cooperation of its two C-terminus functional regions.
    Floettmann JE; Eliopoulos AG; Jones M; Young LS; Rowe M
    Oncogene; 1998 Nov; 17(18):2383-92. PubMed ID: 9811470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential responses to CD40 ligation among Burkitt lymphoma lines that are uniformly responsive to Epstein-Barr virus latent membrane protein 1.
    Henriquez NV; Floettmann E; Salmon M; Rowe M; Rickinson AB
    J Immunol; 1999 Mar; 162(6):3298-307. PubMed ID: 10092782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.
    Nakagomi H; Dolcetti R; Bejarano MT; Pisa P; Kiessling R; Masucci MG
    Int J Cancer; 1994 Apr; 57(2):240-4. PubMed ID: 8157362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
    D'Souza BN; Edelstein LC; Pegman PM; Smith SM; Loughran ST; Clarke A; Mehl A; Rowe M; Gélinas C; Walls D
    J Virol; 2004 Feb; 78(4):1800-16. PubMed ID: 14747545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1).
    Eliopoulos AG; Young LS
    Oncogene; 1998 Apr; 16(13):1731-42. PubMed ID: 9582021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production.
    Eliopoulos AG; Gallagher NJ; Blake SM; Dawson CW; Young LS
    J Biol Chem; 1999 Jun; 274(23):16085-96. PubMed ID: 10347160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
    Kilger E; Kieser A; Baumann M; Hammerschmidt W
    EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of p38 mitogen-activated protein kinase in regulating interleukin-10 gene expression in Burkitt's lymphoma cell lines.
    Horie K; Ohashi M; Satoh Y; Sairenji T
    Microbiol Immunol; 2007; 51(1):149-61. PubMed ID: 17237610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Latent membrane protein 1 associated signaling pathways are important in tumor cells of Epstein-Barr virus negative Hodgkin's disease.
    Knecht H; Berger C; McQuain C; Rothenberger S; Bachmann E; Martin J; Esslinger C; Drexler HG; Cai YC; Quesenberry PJ; Odermatt BF
    Oncogene; 1999 Nov; 18(50):7161-7. PubMed ID: 10597317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.
    Pai S; O'Sullivan BJ; Cooper L; Thomas R; Khanna R
    J Virol; 2002 Feb; 76(4):1914-21. PubMed ID: 11799186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr virus-encoded LMP1 and CD40 mediate IL-6 production in epithelial cells via an NF-kappaB pathway involving TNF receptor-associated factors.
    Eliopoulos AG; Stack M; Dawson CW; Kaye KM; Hodgkin L; Sihota S; Rowe M; Young LS
    Oncogene; 1997 Jun; 14(24):2899-916. PubMed ID: 9205097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p38 MAPK is required for CD40-induced gene expression and proliferation in B lymphocytes.
    Craxton A; Shu G; Graves JD; Saklatvala J; Krebs EG; Clark EA
    J Immunol; 1998 Oct; 161(7):3225-36. PubMed ID: 9759836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10.
    Lambert SL; Martinez OM
    J Immunol; 2007 Dec; 179(12):8225-34. PubMed ID: 18056366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.